A publication by scientists of the Anticancer Fund

Repurposing of drugs for triple negative breast cancer: an overview

Andrea Spini, Sandra Donnini, Pan Pantziarka, Sergio Crispino, Marina Ziche (2020). Repurposing of drugs for triple negative breast cancer: an overview. eCancer 13 July 2020, https://doi.org/10.3332/ecancer.2020.1071

Reflection on Europe's Cancer Mission Board

Our response to the European Commission's public consultation on the Pharmaceutical Strategy Roadmap

Follow-up: Webinar on drug repurposing for cancer in the COVID-19 era

The Anticancer Fund is one of the first philanthropic organisations to join the European Cancer Community 365

Webinar on drug repurposing for cancer in the COVID-19 area

Discover our strategic goals for 2020-2025

test

The Anticancer Fund supports EORTC trial in retroperitoneal sarcoma, a rare and aggressive cancer